Executive Summary
Publicis Groupe S.A. gains stable revenue visibility from a $374M CDC National Tobacco Education Campaign contract via subsidiary Plowshare Group, with $275M already outlayed and performance through March 30, 2026. Upside from $124M unexercised options could boost financials further. Risks include uncertainty on remaining $98M obligated spend and Time & Materials audit exposure, warranting monitoring of outlays and renewals.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Contract Deobligations Alert digest from March 29, 2026.
Investment Signals (1)
- Stable multi-year CDC revenue for Publicis (HIGH)▲
$374M obligated (up to $498M with options) under Time & Materials contract, $275M outlayed, supporting Publicis Groupe S.A. financials through 2026.
Risk Flags (2)
- Execution [MEDIUM RISK]▼
Only $275M outlayed of $374M obligated; remaining $98M spend uncertain ahead of 2026 end.
- Regulatory [MEDIUM RISK]▼
Time & Materials contract exposed to government audits on hours and rates.
Opportunities (2)
- ◆
$124M unexercised options ($498M total potential vs. $374M obligated).
- ◆
Potential follow-on contracts post-2026 in CDC tobacco campaigns.
Sector Themes (1)
- ◆
Full & open competition awards like this $374M CDC tobacco ad contract highlight sustained federal demand for advertising services.
Watch List (2)
- 👁
{"entity"=>"PUBLICIS GROUPE S.A.", "reason"=>"Dependence on $374M contract for stable revenue; $124M options upside.", "trigger"=>"Q1 2026 earnings mention of outlays/options or contract renewal"}
- 👁
{"entity"=>"CDC Tobacco Campaign Funding", "reason"=>"Extended to 2026 with renewal potential post-deobligation period.", "trigger"=>"HHS budget announcements or new RFPs"}
Get daily alerts with 1 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Contract Deobligations Alert
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals